Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Phospholamban is the regulator of the cardiac sarcoplasmic reticulum (SR) Ca(2+)-ATPase activity and an important modulator of basal contractility in the heart. To determine whether all the SR Ca(2+)-ATPase enzymes are subject to regulation by phospholamban in vivo, transgenic mice were generated which overexpressed phospholamban in the heart, driven by the cardiac-specific alpha-myosin heavy chain promoter. Quantitative immunoblotting revealed a twofold increase in the phospholamban protein levels in transgenic hearts compared to wild type littermate hearts. The transgenic mice showed no phenotypic alterations and no changes in heart/body weight, heart/lung weight, and cardiomyocyte size. Isolated unloaded cardiac myocytes from transgenic mice exhibited diminished shortening fraction (63%) and decreased rates of shortening (64%) and relengthening (55%) compared to wild type (100%) cardiomyocytes. The decreases in contractile parameters of transgenic cardiomyocytes reflected decreases in the amplitude (83%) of the Ca2+ signal and prolongation (131%) in the time for decay of the Ca2+ signal, which was associated with a decrease in the apparent affinity of the SR Ca(2+)-ATPase for Ca2+ (56%), compared to wild type (100%) cardiomyocytes. In vivo analysis of left ventricular systolic function using M mode and pulsed-wave Doppler echocardiography revealed decreases in fractional shortening (79%) and the normalized mean velocity of circumferential shortening (67%) in transgenic mice compared to wild type (100%) mice. The differences in contractile parameters and Ca2+ kinetics in transgenic cardiomyocytes and the depressed left ventricular systolic function in transgenic mice were abolished upon isoproterenol stimulation. These findings indicate that a fraction of the Ca(2+)-ATPases in native SR is not under regulation by phospholamban. Expression of additional phospholamban molecules results in: (a) inhibition of SR Ca2+ transport; (b) decreases in systolic Ca2+ levels and contractile parameters in ventricular myocytes; and (c) depression of basal left ventricular systolic function in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Simplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,494
Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic Receptor
Milano, C. A., Allen, L. F., Rockman, H. A., Dolber, P. C., McMinn, T. R., Chien, K. R., Johnson, T. D., Bond, R. A., & Lefkowitz, R. J. (1994) · Science · doi:10.1126/science.8160017 · Cited by 740
Luo, W., Grupp, I. L., Harrer, J., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T., & Kranias, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.3.401 · Cited by 706
Self-citationTissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice.
Subramaniam, A., Jones, W. K., Gulick, J., Wert, S., Neumann, J., & Robbins, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54273-3 · Cited by 469
WLuo, LGrupp, I., JHarrer, SPonniah, GGrupp, JDuffy, J., TDoetschman, & GKranias, E. (1994) · Circulation Research · Cited by 403
Milano, C. A., Dolber, P. C., Rockman, H. A., Bond, R. A., Venable, M. E., Allen, L. F., & Lefkowitz, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.10109 · Cited by 371
Lindemann, J. P., Jones, L. R., Hathaway, D. R., Henry, B. G., & Watanabe, A. M. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33279-4 · Cited by 355
Phospholamban Phosphorylation in Intact Ventricles
Wegener, A. D., Simmerman, H. K., Lindemann, J. P., & Jones, L. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60487-9 · Cited by 300
Movsesian, M. A., Nishikawa, M., & Adelstein, R. S. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39680-1 · Cited by 264
Kiss, E., Jakab, G., Kranias, E. G., & Edes, I. (1994) · Circulation Research · doi:10.1161/01.res.75.2.245 · Cited by 263
Self-citationHoit, B. D., Khoury, S. F., Kranias, E. G., Ball, N., & Walsh, R. A. (1995) · Circulation Research · doi:10.1161/01.res.77.3.632 · Cited by 241
Self-citationPhosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart
Kranias, E. G., & Solaro, R. J. (1982) · Nature · doi:10.1038/298182a0 · Cited by 231
Self-citationPhosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts
Garvey, J. L., Kranias, E. G., & Solaro, R. J. (1988) · Biochemical Journal · doi:10.1042/bj2490709 · Cited by 195
Self-citationMolecular and physiological alterations in murine ventricular dysfunction.
Rockman, H. A., Ono, S., Ross, R. S., Jones, L. R., Karimi, M., Bhargava, V, Ross, J., & Chien, K. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2694 · Cited by 161
Kim, H. W., Steenaart, N. A., Ferguson, D. G., & Kranias, E. G. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40073-2 · Cited by 160
Self-citationColyer, J., & Wang, J. H.-C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47398-5 · Cited by 97
Mechanisms, diagnosis, and treatment of diastolic heart failure
Lenihan, D. J., Gerson, M. C., Hoit, B. D., & Walsh, R. A. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90251-1 · Cited by 80
Self-citationKoss, K. L., Ponniah, S., Jones, W. K., Grupp, I. L., & Kranias, E. G. (1995) · Circulation Research · doi:10.1161/01.res.77.2.342 · Cited by 71
Self-citationMouse phospholamban gene expression during development in vivo and in vitro.
Ganim, J. R., Luo, W., Ponniah, S., Grupp, I. L., Kim, H. W., Ferguson, D. G., Kadambi, V. J., Neumann, J. C., Doetschman, T., & Kranias, E. G. (1992) · Circulation Research · doi:10.1161/01.res.71.5.1021 · Cited by 64
Self-citationIdentification of transgenic mice carrying the CAT gene with PCR amplification.
Ca, W., Nasr-Schirf, D., & Vj, L. (1990) · PubMed · Cited by 44
Application of the immunoblot technique for quantitation of protein levels in cardiac homogenates.
Harrer, J. M., Kiss, E., & Kranias, E. G. (1995) · PubMed · Cited by 35
Self-citation
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
Self-citationSignaling Pathways for Cardiac Hypertrophy and Failure
Hunter, J. J., & Chien, K. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411706 · Cited by 869
Calcium Pumps in Health and Disease
Brini, M., & Carafoli, E. (2009) · Physiological Reviews · doi:10.1152/physrev.00032.2008 · Cited by 676
Metadata
- Authors
- Kadambi, V. J., Ponniah, S., Harrer, J. M., Hoit, B. D., Dorn, G. W., Walsh, R. A., & Kranias, E. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-01-15
- Volume
- 97
- Issue
- 2
- Pages
- 533-539
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2094074899
- Cited by
- 327
- References
- 22
- FWCI
- 20.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.